Velpanat

Velpatasvir 100 mg + Sofosbuvir 400 mg Tablets

Description: Velpatasvir 100 mg + Sofosbuvir 400 mg tablets are a combination antiviral medication used to treat chronic hepatitis C virus (HCV) infection. This fixed-dose combination targets different stages of the HCV life cycle, enhancing the efficacy of treatment.

Salt Composition:

• Velpatasvir: An NS5A inhibitor that interferes with viral replication and assembly.
• Sofosbuvir: A nucleotide analog that inhibits the HCV NS5B polymerase, essential for viral RNA replication.

Key Features:

• Dual Action: Combines two potent antivirals for comprehensive treatment.
• Convenient Dosing: Administered as a single daily tablet.
• Broad Efficacy: Effective against various HCV genotypes.

Benefits:

• High Efficacy: Demonstrated high rates of sustained viral response (SVR) in clinical trials.
• Simplified Regimen: Fixed-dose combination improves adherence to therapy.
• Liver Health: Helps reduce viral load, inflammation, and fibrosis.

American Brand Names:

• Epclusa

Indian Brand Names:

• Velpata-S (Hetero)
• Sofvel (Zydus)
• Velsof (Mylan)
• Sofosvel (Various local brands)

Related Keywords: Velpatasvir 100 mg + Sofosbuvir 400 mg tablets, hepatitis C treatment, HCV combination therapy, antiviral medication, NS5A inhibitor, HCV NS5B polymerase inhibitor, sustained viral response, liver health improvement.